- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00730171
An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
January 19, 2018 updated by: Ironwood Pharmaceuticals, Inc.
An Open-label, Long-term Safety Study of Oral Linaclotide Administered to Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
The objective of this study is to assess the long-term safety of linaclotide administered to patients with chronic constipation (CC) or irritable bowel syndrome with constipation (IBS-C).
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Participants include randomization-ineligible (RI) patients from the lead-in double-blind trials MCP-103-302 (NCT00938717) or MCP-103-303 (NCT00730015), or rollover (RO) patients from the lead-in double-blind trials MCP-103-302 (NCT00938717), MCP-103-303 (NCT00730015), and from the Phase 2 double-blind studies MCP-103-004 (NCT00306748), MCP-103-005 (NCT00258193), and MCP-103-201 (NCT00402337), or MCP-103-202 (NCT00460811).
Study Type
Interventional
Enrollment (Actual)
1743
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35209
- Ironwood Investigational Site
-
Huntsville, Alabama, United States, 35801
- Ironwood Investigational Site
-
-
Arizona
-
Chandler, Arizona, United States, 85224
- Ironwood Investigational Site
-
Phoenix, Arizona, United States, 85020
- Ironwood Investigational Site
-
Tucson, Arizona, United States, 85710
- Ironwood Investigational Site
-
Tucson, Arizona, United States, 85715
- Ironwood Investigational Site
-
Tucson, Arizona, United States, 85741
- Ironwood Investigational Site
-
-
Arkansas
-
Sherwood, Arkansas, United States, 72120
- Ironwood Investigational Site
-
-
California
-
Anaheim, California, United States, 92801
- Ironwood Investigational Site
-
Chula Vista, California, United States, 91910
- Ironwood Investigational Site
-
Encinitas, California, United States, 92024
- Ironwood Investigational Site
-
Garden Grove, California, United States, 92840
- Ironwood Investigational Site
-
Laguna Hills, California, United States, 92653
- Ironwood Investigational Site
-
Los Angeles, California, United States, 90045
- Ironwood Investigational Site
-
Orange, California, United States, 92868
- Ironwood Investigational Site
-
Sacramento, California, United States, 95830
- Ironwood Investigational Site
-
San Carlos, California, United States, 94070
- Ironwood Investigational Site
-
San Diego, California, United States, 92103
- Ironwood Investigational Site
-
San Diego, California, United States, 92108
- Ironwood Investigational Site
-
San Diego, California, United States, 92123
- Ironwood Investigational Site
-
-
Colorado
-
Colorado Springs, Colorado, United States, 80904
- Ironwood Investigational Site
-
-
Connecticut
-
Bristol, Connecticut, United States, 06010
- Ironwood Investigational Site
-
-
Florida
-
Boynton Beach, Florida, United States, 33426
- Ironwood Investigational Site
-
Hollywood, Florida, United States, 33021
- Ironwood Investigational Site
-
Inverness, Florida, United States, 34452
- Ironwood Investigational Site
-
Jacksonville, Florida, United States, 32205
- Ironwood Investigational Site
-
Jacksonville, Florida, United States, 32256
- Ironwood Investigational Site
-
Lauderdale Lakes, Florida, United States, 33319
- Ironwood Investigational Site
-
Miami, Florida, United States, 33156
- Ironwood Investigational Site
-
Pinellas Park, Florida, United States, 33782
- Ironwood Investigational Site
-
Port Orange, Florida, United States, 32129
- Ironwood Investigational Site
-
Tampa, Florida, United States, 33607
- Ironwood Investigational Site
-
-
Georgia
-
Newnan, Georgia, United States, 30263
- Ironwood Investigational Site
-
-
Illinois
-
Peoria, Illinois, United States, 61602
- Ironwood Investigational Site
-
-
Indiana
-
Anderson, Indiana, United States, 46011
- Ironwood Investigational Site
-
-
Iowa
-
Clive, Iowa, United States, 50325
- Ironwood Investigational Site
-
Davenport, Iowa, United States, 52807
- Ironwood Investigational Site
-
-
Kansas
-
Mission, Kansas, United States, 66202
- Ironwood Investigational Site
-
Overland Park, Kansas, United States, 66215
- Ironwood Investigational Site
-
Topeka, Kansas, United States, 66606
- Ironwood Investigational Site
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70809
- Ironwood Investigational Site
-
Metairie, Louisiana, United States, 70006
- Ironwood Investigational Site
-
Monroe, Louisiana, United States, 71201
- Ironwood Investigational Site
-
Shreveport, Louisiana, United States, 71103
- Ironwood Investigational Site
-
-
Maryland
-
Annapolis, Maryland, United States, 21401
- Ironwood Investigational Site
-
Baltimore, Maryland, United States, 21215
- Ironwood Investigational Site
-
Hollywood, Maryland, United States, 20636
- Ironwood Investigational Site
-
Laurel, Maryland, United States, 20707
- Ironwood Investigational Site
-
-
Michigan
-
Chesterfield, Michigan, United States, 48047
- Ironwood Investigational Site
-
Traverse City, Michigan, United States, 49684
- Ironwood Investigational Site
-
Troy, Michigan, United States, 48098
- Ironwood Investigational Site
-
-
Minnesota
-
Plymouth, Minnesota, United States, 55446
- Ironwood Investigational Site
-
-
Mississippi
-
Jackson, Mississippi, United States, 39202
- Ironwood Investigational Site
-
Tupelo, Mississippi, United States, 38801
- Ironwood Investigational Site
-
-
Missouri
-
Jefferson City, Missouri, United States, 65109
- Ironwood Investigational Site
-
-
Nevada
-
Henderson, Nevada, United States, 89104
- Ironwood Investigational Site
-
Las Vegas, Nevada, United States, 89128
- Ironwood Investigational Site
-
-
New Jersey
-
Cedar Knolls, New Jersey, United States, 07927
- Ironwood Investigational Site
-
Marlton, New Jersey, United States, 08053
- Ironwood Investigational Site
-
Ocean City, New Jersey, United States, 07712
- Ironwood Investigational Site
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87108
- Ironwood Investigational Site
-
-
New York
-
Mineola, New York, United States, 11501
- Ironwood Investigational Site
-
Pittsford, New York, United States, 14534
- Ironwood Investigational Site
-
-
North Carolina
-
Asheboro, North Carolina, United States, 27203
- Ironwood Investigational Site
-
Asheville, North Carolina, United States, 28801
- Ironwood Investigational Site
-
Chapel Hill, North Carolina, United States, 27599
- Ironwood Investigational Site
-
Charlotte, North Carolina, United States, 28211
- Ironwood Investigational Site
-
Greensboro, North Carolina, United States, 27408
- Ironwood Investigational Site
-
Harrisburg, North Carolina, United States, 28075
- Ironwood Investigational Site
-
Hickory, North Carolina, United States, 28602
- Ironwood Investigational Site
-
Huntersville, North Carolina, United States, 28078
- Ironwood Investigational Site
-
Jacksonville, North Carolina, United States, 28546
- Ironwood Investigational Site
-
New Bern, North Carolina, United States, 28562
- Ironwood Investigational Site
-
Statesville, North Carolina, United States, 28625
- Ironwood Investigational Site
-
Summerville, North Carolina, United States, 29485
- Ironwood Investigational Site
-
Wilmington, North Carolina, United States, 28401
- Ironwood Investigational Site
-
Winston-Salem, North Carolina, United States, 27103
- Ironwood Investigational Site
-
-
Ohio
-
Beachwood, Ohio, United States, 44122
- Ironwood Investigational Site
-
Cincinnati, Ohio, United States, 45224
- Ironwood Investigational Site
-
Cincinnati, Ohio, United States, 45242
- Ironwood Investigational Site
-
Dayton, Ohio, United States, 45440
- Ironwood Investigational Site
-
Mentor, Ohio, United States, 44060
- Ironwood Investigational Site
-
Sylvania, Ohio, United States, 43560
- Ironwood Investigational Site
-
Wadsworth, Ohio, United States, 44281
- Ironwood Investigational Site
-
Zanesville, Ohio, United States, 43701
- Ironwood Investigational Site
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73116
- Ironwood Investigational Site
-
Yukon, Oklahoma, United States, 73099
- Ironwood Investigational Site
-
-
Pennsylvania
-
Lancaster, Pennsylvania, United States, 17604
- Ironwood Investigational Site
-
Lancaster, Pennsylvania, United States, 19606
- Ironwood Investigational Site
-
Levittown, Pennsylvania, United States, 19056
- Ironwood Investigational Site
-
Pittsburgh, Pennsylvania, United States, 15213
- Ironwood Investigational Site
-
Sellersville, Pennsylvania, United States, 18960
- Ironwood Investigational Site
-
-
South Carolina
-
Anderson, South Carolina, United States, 29621
- Ironwood Investigational Site
-
Charleston, South Carolina, United States, 29414
- Ironwood Investigational Site
-
Simpsonville, South Carolina, United States, 29681
- Ironwood Investigational Site
-
-
Tennessee
-
Bristol, Tennessee, United States, 37620
- Ironwood Investigational Site
-
Chattanooga, Tennessee, United States, 37421
- Ironwood Investigational Site
-
Germantown, Tennessee, United States, 38138
- Ironwood Investigational Site
-
Kingsport, Tennessee, United States, 37660
- Ironwood Investigational Site
-
Nashville, Tennessee, United States, 37203
- Ironwood Investigational Site
-
-
Texas
-
Beaumont, Texas, United States, 77701
- Ironwood Investigational Site
-
El Paso, Texas, United States, 79905
- Ironwood Investigational Site
-
Fort Worth, Texas, United States, 76104
- Ironwood Investigational Site
-
Houston, Texas, United States, 77024
- Ironwood Investigational Site
-
Irving, Texas, United States, 75061
- Ironwood Investigational Site
-
Longview, Texas, United States, 75605
- Ironwood Investigational Site
-
San Antonio, Texas, United States, 78229
- Ironwood Investigational Site
-
Sugar Land, Texas, United States, 77479
- Ironwood Investigational Site
-
-
Utah
-
Ogden, Utah, United States, 84405
- Ironwood Investigational Site
-
Salt Lake City, Utah, United States, 84107
- Ironwood Investigational Site
-
-
Virginia
-
Chesapeake, Virginia, United States, 23320
- Ironwood Investigational Site
-
Lynchburg, Virginia, United States, 24502
- Ironwood Investigational Site
-
-
Washington
-
Spokane, Washington, United States, 99208
- Ironwood Investigational Site
-
Vancouver, Washington, United States, 98664
- Ironwood Investigational Site
-
-
Wisconsin
-
La Crosse, Wisconsin, United States, 54601
- Ironwood Investigational Site
-
Milwaukee, Wisconsin, United States, 53215
- Ironwood Investigational Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Patients must have
- entered study MCP-103-303 or MCP-103-302 and at minimum completed the pre-treatment period or
- completed one of the following studies: MCP-103-004, MCP-103-005, MCP-103-201, MCP-103-202
- Sexually active patients of childbearing potential agree to use birth control
- Females of childbearing potential must have a negative urine pregnancy test prior to dosing
- Lactating females must agree not to breastfeed
- Patient must meet protocol criteria for CC or IBS-C
Exclusion Criteria:
- Patient must not use protocol-defined prohibited medicine
- Patient is planning to receive an investigational drug at any time during the study
- Patient has an unresolved adverse events or a clinically significant finding on a physical examination, 12-lead electrocardiogram, or clinical laboratory test
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Linaclotide
Linaclotide 290 μg/day capsules, administered orally once daily for up to 78 weeks.
Dose reduction to 145 μg/day was permitted at the discretion of the Investigator.
|
Linaclotide capsules, oral, once daily each morning at least 30 minutes before breakfast for the duration of the study.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With at Least One Treatment-Emergent Adverse Event (TEAE)
Time Frame: From first dose of open-label study drug up to 78 weeks
|
For RI and Phase 2 RO participants, an AE that occurred during the study was considered a TEAE if it was not present before the day of the first dose of open-label study drug, or was present before the day of the first dose of open-label study drug but increased in severity on or after that day.
For Phase 3 RO participants, an AE that occurred during the study was considered a TEAE if it was not present before the day of the first dose of double-blind study drug in trial MCP-103-302 or MCP-103-303, or was present before the day of the first dose of double-blind study drug in those trials but increased in severity on or after that day.
Deaths and serious AEs (SAEs) are those that occurred on or after the date of the first dose of open-label study drug, and within 30 days of the date of last dose of open-label study drug.
|
From first dose of open-label study drug up to 78 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2008
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
March 1, 2012
Study Registration Dates
First Submitted
August 5, 2008
First Submitted That Met QC Criteria
August 5, 2008
First Posted (Estimate)
August 8, 2008
Study Record Updates
Last Update Posted (Actual)
February 19, 2018
Last Update Submitted That Met QC Criteria
January 19, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Disease
- Signs and Symptoms, Digestive
- Gastrointestinal Diseases
- Colonic Diseases, Functional
- Colonic Diseases
- Intestinal Diseases
- Syndrome
- Irritable Bowel Syndrome
- Constipation
- Molecular Mechanisms of Pharmacological Action
- Gastrointestinal Agents
- Guanylyl Cyclase C Agonists
- Enzyme Activators
- Linaclotide
Other Study ID Numbers
- MCP-103-305
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Irritable Bowel Syndrome With Constipation
-
ProgenaBiomeRecruitingIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome Characterized by Constipation | Irritable Bowel Syndrome Mixed | Irritable Bowel Syndrome Without Diarrhea | Irritable Bowel | Irritable Bowel Syndrome Aggravated and other conditionsUnited States
-
Federal Stare Budgetary Scientific Institution,...I.M. Sechenov First Moscow State Medical University; RML INVEST, Torkhovsky...CompletedIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome MixedRussian Federation
-
Istanbul Medipol University HospitalTepecik Training and Research Hospital; Bozyaka Training and Research Hospital and other collaboratorsRecruitingIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome MixedTurkey
-
Vasily IsakovRussian Science Foundation; Azbuka vkusa; Federal Research Centre of Nutrition...CompletedIrritable Bowel Syndrome With Constipation | Constipation-predominant Irritable Bowel SyndromeRussian Federation
-
AstraZenecaPeking University First Hospital; The First Affiliated Hospital of Anhui Medical... and other collaboratorsCompletedIrritable Bowel Syndrome With Constipation | Functional ConstipationChina
-
AbbVieIronwood Pharmaceuticals, Inc.Active, not recruitingIrritable Bowel Syndrome With Constipation | Functional ConstipationUnited States, Belgium, Bulgaria, Canada, Estonia, Israel, Italy, Netherlands, Poland, Puerto Rico, Spain, Ukraine, United Kingdom, Germany
-
AbbVieIronwood Pharmaceuticals, Inc.Enrolling by invitationIrritable Bowel Syndrome With Constipation | Functional ConstipationUnited States, Canada, Israel, Netherlands
-
Mayo ClinicAbbVie; Cedars-Sinai Medical Center; Ironwood Pharmaceuticals, Inc.Not yet recruitingIrritable Bowel Syndrome With ConstipationUnited States
-
Massachusetts General HospitalCompleted
-
University of MichiganNational Institute of Neurological Disorders and Stroke (NINDS); National Center...RecruitingIrritable Bowel Syndrome With ConstipationUnited States
Clinical Trials on Linaclotide
-
AbbVieIronwood Pharmaceuticals, Inc.Active, not recruitingIrritable Bowel Syndrome With Constipation | Functional ConstipationUnited States, Belgium, Bulgaria, Canada, Estonia, Israel, Italy, Netherlands, Poland, Puerto Rico, Spain, Ukraine, United Kingdom, Germany
-
Forest LaboratoriesIronwood Pharmaceuticals, Inc.TerminatedIrritable Bowel Syndrome With ConstipationUnited States, Canada
-
Forest LaboratoriesIronwood Pharmaceuticals, Inc.CompletedConstipation | Chronic ConstipationUnited States, Canada
-
Forest LaboratoriesIronwood Pharmaceuticals, Inc.Completed
-
Forest LaboratoriesIronwood Pharmaceuticals, Inc.CompletedChronic ConstipationUnited States, Canada
-
Ironwood Pharmaceuticals, Inc.Forest LaboratoriesCompletedIrritable Bowel Syndrome With ConstipationUnited States
-
Astellas Pharma IncCompleted
-
Changhai HospitalThe First Affiliated Hospital of Nanchang University; The Second Hospital of... and other collaboratorsCompletedBowel Preparation for ColonoscopyChina
-
Astellas Pharma IncCompletedIrritable Bowel Syndrome With Constipation (IBS-C)Japan
-
Ironwood Pharmaceuticals, Inc.CompletedIrritable Bowel Syndrome With ConstipationUnited States, Canada